Back to Search Start Over

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment.

Authors :
Tupinambás U
Aleixo A
Greco D
Source :
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2005 Aug; Vol. 9 (4), pp. 324-9. Date of Electronic Publication: 2005 Nov 01.
Publication Year :
2005

Abstract

Combined antiretroviral therapy results in sustained viral suppression and a decrease in mortality and morbidity due to HIV infection. Intrinsic strength, durability and absence of cross-resistance are key factors in the selection of antiretrovirals. Failure with nelfinavir has been associated with two protease gene mutations, D30N and L90M. The D30N mutation does not result in cross-resistance with other protease inhibitors, and it decreases viral fitness. In order to check for this mutation after failure with nelfinavir, the 246 HIV-1 genotyping test was performed on virus samples from 55 patients with failure of nelfinavir as the first protease inhibitor. Most (84%) of the viral strains were of subtype B. Nucleosides associated with mutations (NAM) were observed in 80% of the tests; no INS69, complex 151, K65R and L74V mutations, which give multi-resistance to nucleoside analogue reverse transcriptase inhibitors to tenofovir and DDI, respectively, were observed. In the tests for protease gene mutations, the D30N mutation was found in 57%, L90M in 18% and the wild-type virus in 25%. These data are similar to published reports, showing that alternative therapies used after failure with nelfinavir may be more successful, as the D30N mutation does not cause cross-resistance to other protease inhibitors.

Details

Language :
English
ISSN :
1413-8670
Volume :
9
Issue :
4
Database :
MEDLINE
Journal :
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
Publication Type :
Academic Journal
Accession number :
16270125
Full Text :
https://doi.org/10.1590/s1413-86702005000400009